These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 35980281)

  • 21. Status of COVID-19 vaccination around South Asia.
    Hayat M; Uzair M; Ali Syed R; Arshad M; Bashir S
    Hum Vaccin Immunother; 2022 Dec; 18(1):2016010. PubMed ID: 35061956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 vaccine candidates in rapid development.
    Li L; Guo P; Zhang X; Yu Z; Zhang W; Sun H
    Hum Vaccin Immunother; 2021 Mar; 17(3):644-653. PubMed ID: 33121319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive aspects of the mRNA platform for SARS-CoV-2 vaccines.
    Hajissa K; Mussa A
    Hum Vaccin Immunother; 2021 Aug; 17(8):2445-2447. PubMed ID: 33830862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination Setting of Patients with Autoimmune Diseases in Times of Severe Acute Respiratory Syndrome Coronavirus Type 2 Pandemic Using the Example of Multiple Sclerosis Patients: A Longitudinal Multicenter Study.
    Heidler F; Baldt J; Frahm N; Langhorst SE; Mashhadiakbar P; Streckenbach B; Zettl UK; Richter J
    Eur Neurol; 2022; 85(2):104-111. PubMed ID: 34743082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.
    Neuhann JM; Stemler J; Carcas A; Frías-Iniesta J; Bethe U; Heringer S; Tischmann L; Zarrouk M; Cüppers A; König F; Posch M; Cornely OA
    Trials; 2022 Oct; 23(1):865. PubMed ID: 36209129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].
    Lee YJ; Kim SE; Park YE; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Myung SJ;
    Korean J Gastroenterol; 2021 Aug; 78(2):117-128. PubMed ID: 34446634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Super-rapid race for saving lives by developing COVID-19 vaccines.
    Uttarilli A; Amalakanti S; Kommoju PR; Sharma S; Goyal P; Manjunath GK; Upadhayay V; Parveen A; Tandon R; Prasad KS; Dakal TC; Ben Shlomo I; Yousef M; Neerathilingam M; Kumar A
    J Integr Bioinform; 2021 Mar; 18(1):27-43. PubMed ID: 33761582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primer of COVID-19 Vaccines for the Perioperative Physician.
    Lynch LR; Clifford H; Ko R; Hache M; Sun W
    J Neurosurg Anesthesiol; 2022 Jan; 34(1):101-106. PubMed ID: 34870630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
    Wiysonge CS; Ndwandwe D; Ryan J; Jaca A; Batouré O; Anya BM; Cooper S
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-3. PubMed ID: 33684019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 vaccines: what do we know so far?
    Dhillon P; Altmann D; Male V
    FEBS J; 2021 Sep; 288(17):4996-5009. PubMed ID: 34288409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper.
    Gerotziafas GT; Catalano M; Theodorou Y; Dreden PV; Marechal V; Spyropoulos AC; Carter C; Jabeen N; Harenberg J; Elalamy I; Falanga A; Fareed J; Agathaggelou P; Antic D; Antignani PL; Bosch MM; Brenner B; Chekhonin V; Colgan MP; Dimopoulos MA; Douketis J; Elnazar EA; Farkas K; Fazeli B; Fowkes G; Gu Y; Gligorov J; Ligocki MA; Indran T; Kannan M; Kantarcioglu B; Kasse AA; Konstantinidis K; Leivano F; Lewis J; Makatsariya A; Mbaye PM; Mahé I; Panovska-Stavridis I; Olinic DM; Papageorgiou C; Pecsvarady Z; Pillon S; Ramacciotti E; Abdel-Razeq H; Sabbah M; Sassi M; Schernthaner G; Siddiqui F; Shiomura J; Slama-Schwok A; Wautrecht JC; Tafur A; Taher A; Klein-Wegel P; Zhai Z; Zoubida TM;
    Thromb Haemost; 2021 Aug; 121(8):992-1007. PubMed ID: 34169495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 vaccines, where do we stand?
    Fischer A
    C R Biol; 2021 Jun; 344(1):43-55. PubMed ID: 34213848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of the safety and efficacy of current COVID-19 vaccines.
    Huang Z; Su Y; Zhang T; Xia N
    Front Med; 2022 Feb; 16(1):39-55. PubMed ID: 35122210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.
    Hunter CM; Chou WS; Webb Hooper M
    Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis.
    Truong J; Bakshi S; Wasim A; Ahmad M; Majid U
    Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34244738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge and Behaviours towards Immunisation Programmes: Vaccine Hesitancy during the COVID-19 Pandemic Era.
    Dettori M; Arghittu A; Castiglia P
    Int J Environ Res Public Health; 2022 Apr; 19(7):. PubMed ID: 35410045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Effectiveness of Global COVID-19 Vaccination Campaign.
    He D; Ali ST; Fan G; Gao D; Song H; Lou Y; Zhao S; Cowling BJ; Stone L
    Emerg Infect Dis; 2022 Sep; 28(9):1873-1876. PubMed ID: 35914516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdisciplinary research before, during and after COVID-19 vaccination in Chile: a virtuoso collaboration with future perspectives.
    Torres JP; Basso L; Saure D; Zuñiga M; Couve A; Farfán M; de la Maza V; Campos N; O'Ryan M
    Front Public Health; 2024; 12():1354645. PubMed ID: 38633235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.